Charles Robertson
Concepts (527)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 781 | 3.440 |
Why?
| | Gastrointestinal Microbiome | 32 | 2026 | 771 | 2.610 |
Why?
| | RNA, Ribosomal, 16S | 46 | 2026 | 558 | 1.650 |
Why?
| | Bacteria | 32 | 2026 | 889 | 1.620 |
Why?
| | Cystic Fibrosis | 13 | 2026 | 1158 | 0.950 |
Why?
| | Otitis Media | 6 | 2025 | 181 | 0.880 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 676 | 0.870 |
Why?
| | Feces | 17 | 2025 | 513 | 0.770 |
Why?
| | Intestines | 9 | 2017 | 358 | 0.720 |
Why?
| | Metagenome | 10 | 2019 | 149 | 0.690 |
Why?
| | Nasopharynx | 5 | 2024 | 73 | 0.650 |
Why?
| | Rhinitis | 6 | 2020 | 171 | 0.620 |
Why?
| | Biodiversity | 11 | 2020 | 426 | 0.610 |
Why?
| | Water Microbiology | 8 | 2018 | 90 | 0.610 |
Why?
| | Sinusitis | 6 | 2020 | 228 | 0.580 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 81 | 0.530 |
Why?
| | Colon | 4 | 2025 | 304 | 0.500 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 141 | 0.490 |
Why?
| | Phylogeny | 13 | 2020 | 1015 | 0.490 |
Why?
| | Archaea | 2 | 2008 | 86 | 0.490 |
Why?
| | Air Microbiology | 2 | 2015 | 50 | 0.490 |
Why?
| | Ileum | 4 | 2020 | 111 | 0.460 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 824 | 0.460 |
Why?
| | Breast Feeding | 6 | 2025 | 448 | 0.450 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2026 | 636 | 0.450 |
Why?
| | RNA, Bacterial | 8 | 2018 | 189 | 0.420 |
Why?
| | Sputum | 6 | 2026 | 308 | 0.410 |
Why?
| | Database Management Systems | 1 | 2013 | 50 | 0.400 |
Why?
| | Oropharynx | 3 | 2026 | 46 | 0.400 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.390 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.390 |
Why?
| | User-Computer Interface | 1 | 2013 | 164 | 0.370 |
Why?
| | Aerosols | 1 | 2013 | 186 | 0.360 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.350 |
Why?
| | Geologic Sediments | 2 | 2008 | 45 | 0.350 |
Why?
| | Trachea | 4 | 2023 | 261 | 0.340 |
Why?
| | Colitis | 3 | 2025 | 280 | 0.340 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 149 | 0.330 |
Why?
| | HIV Infections | 5 | 2025 | 3079 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.320 |
Why?
| | Crohn Disease | 4 | 2020 | 260 | 0.320 |
Why?
| | Inflammation | 11 | 2025 | 2877 | 0.310 |
Why?
| | Humans | 82 | 2026 | 144261 | 0.300 |
Why?
| | Dysbiosis | 5 | 2023 | 187 | 0.300 |
Why?
| | DNA, Bacterial | 8 | 2021 | 342 | 0.300 |
Why?
| | Lung | 7 | 2021 | 4108 | 0.290 |
Why?
| | Genes, rRNA | 5 | 2015 | 42 | 0.280 |
Why?
| | Male | 55 | 2026 | 72035 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 265 | 0.270 |
Why?
| | Female | 56 | 2026 | 77976 | 0.270 |
Why?
| | Software | 1 | 2013 | 690 | 0.270 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 180 | 0.270 |
Why?
| | Case-Control Studies | 15 | 2020 | 3592 | 0.260 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2026 | 549 | 0.260 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.250 |
Why?
| | Mice | 23 | 2025 | 18329 | 0.250 |
Why?
| | Legionella | 2 | 2017 | 9 | 0.240 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2026 | 12 | 0.240 |
Why?
| | Animals | 32 | 2025 | 38030 | 0.240 |
Why?
| | Mycobiome | 1 | 2026 | 9 | 0.240 |
Why?
| | Capsule Endoscopy | 1 | 2026 | 25 | 0.240 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 234 | 0.240 |
Why?
| | Dietary Supplements | 3 | 2019 | 575 | 0.240 |
Why?
| | HIV-1 | 2 | 2024 | 895 | 0.230 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2929 | 0.230 |
Why?
| | Fatty Liver | 2 | 2021 | 251 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 222 | 0.230 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 221 | 0.230 |
Why?
| | Drinking Water | 3 | 2017 | 97 | 0.230 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.230 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 60 | 0.230 |
Why?
| | Environmental Microbiology | 1 | 2005 | 57 | 0.230 |
Why?
| | Adult | 32 | 2026 | 40262 | 0.220 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 330 | 0.220 |
Why?
| | Drug Resistance | 2 | 2017 | 153 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | Ear, Middle | 5 | 2025 | 85 | 0.220 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.220 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 177 | 0.220 |
Why?
| | Construction Materials | 2 | 2015 | 18 | 0.220 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 147 | 0.210 |
Why?
| | Child | 23 | 2026 | 22537 | 0.210 |
Why?
| | Lyases | 1 | 2024 | 16 | 0.210 |
Why?
| | Fungi | 1 | 2026 | 161 | 0.210 |
Why?
| | Bacteremia | 2 | 2018 | 221 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 100 | 0.210 |
Why?
| | Metagenomics | 3 | 2019 | 181 | 0.210 |
Why?
| | Ecosystem | 2 | 2007 | 589 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 71 | 0.210 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 454 | 0.210 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 478 | 0.200 |
Why?
| | Liver | 3 | 2020 | 1884 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 103 | 0.200 |
Why?
| | Butyrates | 1 | 2024 | 67 | 0.200 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5988 | 0.200 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3842 | 0.200 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 396 | 0.200 |
Why?
| | Respiratory System | 2 | 2016 | 149 | 0.200 |
Why?
| | Diet, Western | 2 | 2022 | 86 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 251 | 0.190 |
Why?
| | Premature Birth | 3 | 2017 | 380 | 0.190 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 582 | 0.190 |
Why?
| | Alternative Splicing | 1 | 2025 | 247 | 0.190 |
Why?
| | Milk, Human | 3 | 2023 | 172 | 0.190 |
Why?
| | Staphylococcus | 4 | 2017 | 74 | 0.190 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 164 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 252 | 0.180 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.180 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 365 | 0.180 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.180 |
Why?
| | Iron | 2 | 2016 | 359 | 0.180 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1168 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 388 | 0.180 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 208 | 0.180 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1906 | 0.180 |
Why?
| | Infant | 12 | 2025 | 10022 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Diet | 3 | 2025 | 1271 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 198 | 0.170 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 388 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Transcriptome | 3 | 2021 | 1044 | 0.160 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.160 |
Why?
| | Adolescent | 19 | 2026 | 22281 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.160 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 57 | 0.160 |
Why?
| | Perilipin-2 | 2 | 2017 | 40 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 233 | 0.160 |
Why?
| | Groundwater | 1 | 2020 | 41 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5813 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Hot Springs | 2 | 2012 | 9 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 522 | 0.160 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.150 |
Why?
| | Respiratory System Agents | 1 | 2020 | 23 | 0.150 |
Why?
| | Inflammation Mediators | 2 | 2020 | 508 | 0.150 |
Why?
| | Biofilms | 3 | 2017 | 278 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 142 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 1767 | 0.150 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1054 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 410 | 0.150 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4556 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 40 | 0.150 |
Why?
| | Chronic Disease | 7 | 2022 | 1812 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 181 | 0.140 |
Why?
| | Middle Aged | 21 | 2024 | 35762 | 0.140 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.140 |
Why?
| | Diet, High-Fat | 2 | 2017 | 261 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2359 | 0.140 |
Why?
| | Biomarkers | 6 | 2025 | 4254 | 0.140 |
Why?
| | Child, Preschool | 10 | 2026 | 11774 | 0.140 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 127 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 16 | 0.140 |
Why?
| | Body Mass Index | 4 | 2020 | 2420 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 14 | 0.140 |
Why?
| | Burns | 1 | 2023 | 376 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 61 | 0.130 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 320 | 0.130 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.130 |
Why?
| | Immunity, Innate | 3 | 2019 | 846 | 0.130 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 13 | 0.130 |
Why?
| | Quinolones | 1 | 2020 | 201 | 0.130 |
Why?
| | Aminophenols | 1 | 2020 | 201 | 0.130 |
Why?
| | Infant, Newborn | 8 | 2025 | 6424 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 442 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 74 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 640 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 556 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 352 | 0.120 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 321 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.120 |
Why?
| | Pedigree | 3 | 2025 | 513 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 121 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 67 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 19 | 0.120 |
Why?
| | Lipid Metabolism | 2 | 2020 | 525 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 6 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 69 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 62 | 0.120 |
Why?
| | Respiration, Artificial | 3 | 2023 | 707 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Cytokines | 3 | 2025 | 2061 | 0.110 |
Why?
| | Young Adult | 11 | 2021 | 13990 | 0.110 |
Why?
| | Base Sequence | 3 | 2015 | 2187 | 0.110 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.110 |
Why?
| | Lactobacillus | 3 | 2022 | 28 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2025 | 3119 | 0.110 |
Why?
| | Dietary Fats | 1 | 2017 | 313 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.110 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 160 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 60 | 0.110 |
Why?
| | Nose | 1 | 2015 | 68 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 40 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
| | Biota | 1 | 2015 | 35 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 267 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 195 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 28 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 52 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 7970 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 244 | 0.110 |
Why?
| | Rats | 6 | 2023 | 5592 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 129 | 0.100 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 130 | 0.100 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 62 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 653 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 48 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 47 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 674 | 0.100 |
Why?
| | Cecum | 3 | 2020 | 37 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 105 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3313 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 94 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 982 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 62 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 21 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1497 | 0.100 |
Why?
| | Cities | 1 | 2013 | 143 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | New York City | 1 | 2013 | 89 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 67 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 680 | 0.100 |
Why?
| | Saliva | 1 | 2015 | 249 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 114 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 844 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 965 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2019 | 1165 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 341 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2020 | 624 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2014 | 124 | 0.090 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.090 |
Why?
| | Prednisone | 1 | 2013 | 221 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 236 | 0.090 |
Why?
| | Aged | 11 | 2023 | 25850 | 0.090 |
Why?
| | Infant Food | 1 | 2013 | 64 | 0.090 |
Why?
| | Seawater | 1 | 2012 | 31 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2014 | 246 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 242 | 0.090 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 248 | 0.090 |
Why?
| | Paneth Cells | 1 | 2012 | 20 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 242 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.090 |
Why?
| | Mexico | 2 | 2012 | 233 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7180 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 70 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 52 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 144 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 832 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 35 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 275 | 0.080 |
Why?
| | Autoimmunity | 2 | 2015 | 924 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1495 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 261 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1147 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 412 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3157 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 166 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 425 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 91 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 3057 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1833 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 399 | 0.070 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.070 |
Why?
| | RNA, Archaeal | 1 | 2008 | 11 | 0.070 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 356 | 0.070 |
Why?
| | Cohort Studies | 5 | 2019 | 5935 | 0.070 |
Why?
| | DNA, Archaeal | 1 | 2008 | 18 | 0.070 |
Why?
| | Indoles | 1 | 2013 | 501 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 157 | 0.070 |
Why?
| | Weight Loss | 1 | 2014 | 832 | 0.070 |
Why?
| | Exome | 2 | 2020 | 227 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2516 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 148 | 0.070 |
Why?
| | Methane | 2 | 2020 | 51 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 67 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 789 | 0.060 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 11 | 0.060 |
Why?
| | Fatty Acids | 2 | 2022 | 450 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 919 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 60 | 0.060 |
Why?
| | Models, Statistical | 1 | 2011 | 677 | 0.060 |
Why?
| | Freezing | 1 | 2007 | 85 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 2025 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 981 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 71 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 736 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 346 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 110 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 197 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 103 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2501 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1092 | 0.050 |
Why?
| | Body Composition | 2 | 2021 | 704 | 0.050 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 152 | 0.050 |
Why?
| | Water Purification | 2 | 2017 | 157 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2603 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 40 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 187 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 129 | 0.050 |
Why?
| | Treatment Outcome | 5 | 2020 | 11643 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 975 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 54 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 847 | 0.050 |
Why?
| | Geography | 2 | 2014 | 203 | 0.050 |
Why?
| | Choline | 1 | 2024 | 136 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2829 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1533 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 561 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 118 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4562 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8243 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 104 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 850 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 79 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1134 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 218 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 180 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2870 | 0.050 |
Why?
| | Water | 2 | 2018 | 469 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1172 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 574 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 278 | 0.040 |
Why?
| | Brain | 1 | 2014 | 2930 | 0.040 |
Why?
| | Gastritis | 1 | 2022 | 115 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 203 | 0.040 |
Why?
| | Enteritis | 1 | 2022 | 103 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 60 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 315 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 673 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 455 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2926 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1468 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2111 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 778 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 610 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 33 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 221 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 727 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 233 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 99 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 954 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 88 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2879 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 547 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 229 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 51 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 360 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 75 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 448 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 181 | 0.030 |
Why?
| | Collagen Type II | 1 | 2018 | 54 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 118 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 109 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2020 | 377 | 0.030 |
Why?
| | Risk Factors | 3 | 2017 | 10699 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 15 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 108 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 98 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 73 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 45 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 4278 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 166 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 451 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 479 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 67 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 199 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1253 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 94 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 69 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 88 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 640 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 889 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 27 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 140 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 17 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 370 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 130 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3857 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 204 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 998 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 180 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 32 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 40 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 129 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 136 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 43 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 79 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 508 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 31 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 207 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 49 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1460 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 916 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 89 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 41 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 53 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 168 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 122 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 201 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 230 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 96 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 502 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2026 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 57 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 519 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2143 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 37 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1487 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 354 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 307 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 151 | 0.020 |
Why?
| | Connectome | 1 | 2014 | 95 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 397 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 100 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 230 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 331 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 43 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 321 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 358 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 288 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1867 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 311 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 29 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 316 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 611 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 51 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1964 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 405 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 64 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 105 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2917 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 55 | 0.020 |
Why?
| | Suction | 1 | 2011 | 33 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1339 | 0.020 |
Why?
| | Skin | 1 | 2016 | 754 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 109 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 474 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 155 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 390 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 546 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 976 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 248 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 530 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1125 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 368 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5389 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2312 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 541 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 354 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 758 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 206 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 535 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2840 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 475 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 318 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4146 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1075 | 0.020 |
Why?
| | Risk | 1 | 2011 | 909 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 4085 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1782 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 852 | 0.020 |
Why?
| | Mining | 1 | 2007 | 36 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1510 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1422 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.010 |
Why?
| | Hospitalization | 1 | 2015 | 2424 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 678 | 0.010 |
Why?
| | United States | 1 | 2015 | 15876 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 17009 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|